BioCentury
ARTICLE | Product Development

Navigating IP strategies in the world of digital therapeutics

Digital therapeutics makers are looking to the tech industry for IP strategies

November 16, 2019 4:02 AM UTC

For digital therapeutics, which straddle life sciences and tech, IP may be less important to creating value than the data they generate. As biopharma companies move into the world of digital therapeutics, they will need to adopt new IP strategies that balance the competing interests of both sectors.

Digital therapeutics, along with digital biomarkers and tools for disease management, represent both an opportunity and a source of new competition from the sphere of digital health that is fast becoming part of the landscape in the biopharma industry. ...

BCIQ Company Profiles

Click Therapeutics Inc.